ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

LATPS, a novel prognostic signature based on tumor microenvironment of lung adenocarcinoma to better predict survival and immunotherapy response

Huang, Jihong; Yuan, Lu; Huang, Wenqi; Liao, Liwei; Zhu, Xiaodi; Wang, Xiaoqing; Li, Jiaxin; Liang, Wenyu; Wu, Yuting; Liu, Xiaocheng; Yu, Dong; Zheng, Yunna; Guan, Jian*; Zhan, Yongzhong*; Liu, Laiyu*南方医科大学
Frontiers in Immunology2022-11-24DOI: 10.3389/fimmu.2022.1064874
2被引7阅读
引用收藏
分享

摘要

BackgroundClinically, only a minority of patients benefit from immunotherapy and few efficient biomarkers have been identified to distinguish patients who would respond to immunotherapy. The tumor microenvironment (TME) is reported to contribute to immunotherapy response, but details remain unknown. We aimed to construct a prognostic model based on the TME of lung adenocarcinoma (LUAD) to predict the prognosis and immunotherapy efficacy. MethodsWe integrated computational algorithms to describe the immune infiltrative landscape of LUAD patients. With the least absolute shrinkage and selection operator (LASSO) and Cox regression analyses, we developed a LUAD tumor microenvironment prognostic signature (LATPS). Subsequently, the immune characteristics and the benefit of immunotherapy in LATPS-defined subgroups were analyzed. RNA sequencing of tumor samples from 28 lung cancer patients treated with anti-PD-1 therapy was conducted to verify the predictive value of the LATPS. ResultsWe constructed the LATPS grounded on four genes, including UBE2T, KRT6A, IRX2, and CD3D. The LATPS-low subgroup had a better overall survival (OS) and tended to have a hot immune phenotype, which was characterized by an elevated abundance of immune cell infiltration and increased activity of immune-related pathways. Additionally, tumor immune dysfunction and exclusion (TIDE) score was markedly decreased in the LATPS-low subgroup, indicating an enhanced opportunity to benefit from immunotherapy. Survival analysis in 28 advanced lung cancer patients treated with an anti-PD-1 regimen at Nanfang hospital revealed that the LATPS-low subgroup had better immunotherapy benefit. ConclusionLATPS is an effective predictor to distinguish survival, immune characteristics, and immunotherapy benefit in LUAD patients.

学科与关键词

关键词
immunotherapyprognosisimmune infiltrationtumor microenvironmentLUAD
相关
加载中…
  • Immune signature-based risk stratification and prediction of immune checkpoint inhibitor's efficacy for lung adenocarcinoma.
    Yi, Ming; Li, Anping; Zhou, Linghui; Chu, Qian; Luo, Suxia*; Wu, Kongming*Cancer Immunol Immunother, 2021, 70(6): 1705-1719.
  • Characterization of the Immune Cell Infiltration Landscape Uncovers Prognostic and Immunogenic Characteristics in Lung Adenocarcinoma
    Wang, Xin; Xu, Zhenyi; Liu, Zhilin; Lin, Weihao; Cao, Zheng; Feng, Xiaoli; Gao, Yibo*; He, Jie*Frontiers in Genetics, 2022, 13: 902577.被引 2
  • Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinoma
    Cao, Kui; Liu, Mingdong; Ma, Keru; Jiang, Xiangyu; Ma, Jianqun*; Zhu, Jinhong*Cancer Immunology, Immunotherapy, 2022, 71(6): 1295-1311.被引 14
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-11-24
卷期
第 13 卷
页码
1064874
DOI
10.3389/fimmu.2022.1064874
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; President Foundation of Nanfang Hospital, Southern Medical University; Clinical Research Program of Nanfang Hospital, Southern Medical University; [81870026]; [2020C044]; [2018CR019]; [2018CR021]; [2020CR025]

作者

  • H

    Huang, Jihong (第一作者)

    southern med univ

  • Y

    Yuan, Lu

    southern med univ

查看全部 15 位作者收起作者
  • H

    Huang, Wenqi

    southern med univ

  • L

    Liao, Liwei

    southern med univ

  • Z

    Zhu, Xiaodi

    southern med univ

  • W

    Wang, Xiaoqing

    southern med univ

  • L

    Li, Jiaxin

    southern med univ

  • L

    Liang, Wenyu

    southern med univ

  • W

    Wu, Yuting

  • L

    Liu, Xiaocheng

    southern med univ

  • Y

    Yu, Dong

    southern med univ

  • Z

    Zheng, Yunna

    southern med univ

  • G

    Guan, Jian (通讯)

    southern med univ

  • Z

    Zhan, Yongzhong (通讯)

    southern med univ

  • L

    Liu, Laiyu (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417